ACE inhibition modulates transforming growth factor-β receptors in the young rat

Pediatric Nephrology

Volumn 18, Issue 9, 2003, Pages 865-871

  Kang, Nam Soo ^a   Yim, Hyung Eun ^a   Bae, In Sun ^a   Choi, Jeong Hoon ^a   Choi, Byung Min ^a   Yoo, Kee Hwan ^a   Hong, Young Sook ^a   Lee, Joo Won ^a   Kim, Soon Kyum ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Angiotensin converting enzyme inhibitors; Renin angiotensin system; Transforming growth factor receptor; Transforming growth factor 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG VEHICLE; ENALAPRIL; GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; GROWTH DISORDER; GROWTH RETARDATION; IMMUNOHISTOCHEMISTRY; KIDNEY DEVELOPMENT; KIDNEY MASS; NEWBORN; NEWBORN MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE I; AGE FACTORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; ENALAPRIL; FEMALE; GENE EXPRESSION; KIDNEY; ORGAN SIZE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RENIN-ANGIOTENSIN SYSTEM;

EID: 0141746388     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1220-3     Document Type: Article

References (37)

1. Wolf G (1995) Angiotensin as a renal growth factor. Adv Exp Med Biol 377:225-236
2. Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH (2002) Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 52:325-332
3. Norman JT (1991) The role of angiotensin II in renal growth. Renal Physiol Biochem 14:175-185
4. Gomez RA, Lynch KR, Sturgill BC, Elwood JP, Chevalier RL, Carey RM, Peach MJ (1989) Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 257:F850-F858
5. Yoo KH, Wolstenholme JT, Chevalier RL (1997) Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr Res 42:588-592
6. Khalil A, Tullus K, Bakhiet M, Burman LG, Jaremko G, Brauner A (2000) Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. J Urol 164:186-191
7. Moses HL, Yang EY, Pietenpol JA (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247
8. Robert AB, Sporn MB (1991) The transforming growth factor-βs. In: Sporn MB, Robert AB (eds) Peptide growth factors and their receptors. Springer-Verlag, Berlin Heidelberg New York pp 419-472
9. Basile DP, Hammerman MR (1998) TGF-beta in renal development and renal growth. Miner Electrolyte Metab 24:144-148
10. Liu A, Dardik A, Ballermann BJ (1999) Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation. Kidney Int 56:1334-1348
11. Yang SP, Woolf AS, Yuan HT, Scott RJ, Risdon RA, O'Hare MJ, Winyard PJ (2000) Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations. Am J Pathol 157:1633-1647
12. Massague J (1990) The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641
13. Wrana JL, Attisano L, Cacamo J, Zentella A, Dooby J, Laiho M, Wang X-F, Massague J (1992) TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014
14. Cehn C, Wang X-F, Sun L (1997) Expression of transforming growth factor β type III receptor restores autocrine TGFβ1 activity in human breast cancer MCF-7 cells. J Biol Chem 272:12862-12867
15. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N, Peach MJ, Carey RM (1988) Renin and angiotensinogen gene expression and intrarenal distribution during ACE inhibition. Am J Physiol 254:F900-F906
16. Liu A, Ballermann BJ (1998) TGF-beta type II receptor in rat renal vascular development: localization to juxtaglomerular cells. Kidney Int 53:716-725
17. Moller JC, Skriver E (1985) Quantitative ultrastructure of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch A Pathol Anat Histopathol 406:389-406
18. Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502
19. Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF (1994) A transforming growth factor beta type I receptor that signals to activate gene expression. Science 263:87-89
20. Choi ME, Kim EG, Huang Q, Ballermann BJ (1993) Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Int 44:948-958
21. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utiliziing the principle of protein-dye binding. Anal Biochem 72:248-254
22. Gomez RA, Tufro-McReddie A, Norwood VF, Harris M, Pentz ES (1994) Renin-angiotensin system: kidney growth and development. Exp Nephrol 2:130
23. Pryde PG, Sedman AB, Nugent CE, Barr M (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582
24. Miyazaki Y, Tsuchida S, Fogo A, Ichikawa I (1999) The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 55:1683-1695
25. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA (1995) Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-FI15
26. Esther RE, Howard TE, Marino EM, Goddard JM, Capecchi MR, Berstein KE (1996) Mice lacking angiotensin converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab Invest 74:953-965
27. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimuraa F, Nishimura H, Fogo A, Utsunomiya H, Inagami Y, Ichikawa I (1998) Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101:755-760
28. Yoo KH, Hong YS, Lee JW, Kim SK (1998) Angiotensin II (ANG II) increases fibrosis, apoptosis, and cell proliferation but decreases Bcl-2 expression in rat kidney (abstract). J Am Soc Nephrol 9:492
29. Yoo KH, Choe J-H, Kim MK, Hong YS, Lee JW, Kim SK (2000) Angiotensin converting enzyme inhibition modulates platelet derived growth factors, receptors and alpha smooth muscle actin expression in the neonatal rat kidney (abstract). J Am Soc Nephrol 11:385
30. Yoo KH, Thornhill BA, Wolstenholme JT, Chevalier RL (1998) Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am J Hypertens 11:715-722
31. Yoo KH, Thornhill BA, Chevalier RL (2000) Angiotensin stimulates TGF-beta and clusterin in the hydronephrotic neonatal rat kidney. Am J Physiol 278:R640-R645
32. Mariano JM, Montuenga LM, Prentice MA, Cuttitta F, Jakowlew SB (1998) Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis. Int J Dev Biol 42:1125-1136
33. Choi ME, Liu A, Ballermann BJ (1997) Differential expression of transforming growth factor-beta receptors in rat kidney development. Am J Physiol 273:F386-F395
34. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA (1996) Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436-1446
35. Chen RH, Ebner R, Derynck R (1993) Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260:1335-1338
36. Wolf G, Ziyadeh FN, Stahl RA (1999) Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 77:556-564
37. Guh JY, Yang ML, Yang YL, Chang CC, Chuang LY (1996) Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions. J Am Soc Nephrol 7:1207-1215